Delfi Diagnostics
Delfi Diagnostics detect cancer early, when it is most curable, using high precision non-invasive blood tests. It uses artificial intelligence and genome sequencing to detect unique patterns of DNA fragmentation in the blood of patients.
HealthcareBioTech
Baltimore, MD
$100M-250M
Funding
51-100
Employees
Company Mission
Changing the paradigm for early detection of cancer
Looking for a better job?
Discover the best career opportunities with the best company cultures for you.
Do you work at this company?
Connect your business to thousands of engaged professionals in your city and beyond.
